IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,129 | +63.5% | 2,446 | +152.9% | 0.00% | – |
Q2 2023 | $6,808 | +289.7% | 967 | +238.1% | 0.00% | – |
Q1 2023 | $1,747 | +74.7% | 286 | +460.8% | 0.00% | – |
Q2 2022 | $1,000 | -92.9% | 51 | -94.0% | 0.00% | – |
Q1 2022 | $14,000 | +16.7% | 847 | +36.6% | 0.00% | – |
Q4 2021 | $12,000 | -20.0% | 620 | +5.3% | 0.00% | -100.0% |
Q3 2021 | $15,000 | +87.5% | 589 | +86.4% | 0.00% | – |
Q2 2021 | $8,000 | +100.0% | 316 | +156.9% | 0.00% | – |
Q1 2021 | $4,000 | +300.0% | 123 | +151.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 49 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |